Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ACXP
$1.30
-0.76%
ACXP
· Acurx Pharmaceuticals, Inc.
$1.30
-0.01 (-0.76%)
At close · Oct 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, our independent registered public accounting firm has expressed substantial doubt about our ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.09M
Shares
5.27M
Volume · Oct 6
9350
Avg daily vol (3M)
128.18K
All webcasts
Earnings call · FY2021 Q2
Acurx Pharmaceuticals, Inc. (ACXP) Q2 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$11.40
Net income
-$4.00M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 16, 2021 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 13, 2021 · complete as-filed document